TickerFacts.

A business in context

VRCA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-17 · 0002046750-26-000004

  2. 4 · Ownership change

    Report date 2026-08-14 · 0002043558-26-000005

  3. 4 · Ownership change

    Report date 2026-08-17 · 0001579649-26-000005

  4. 4 · Ownership change

    Report date 2026-08-18 · 0001556327-26-000003

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001660334-26-000025

  6. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338273 · Items 2.02,9.01

  7. 4 · Ownership change

    Report date 2026-06-05 · 0002046750-26-000002

  8. 4 · Ownership change

    Report date 2026-06-05 · 0002043558-26-000002

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001814892-26-000002

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001814338-26-000002

  11. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-263722 · Items 5.02,5.07,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001660334-26-000014

  13. 8-K · Current report

    Report date 2026-05-12 · 0001193125-26-219395 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-05 · 0001193125-26-163961

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001660334-26-000008

  16. 8-K · Current report

    Report date 2026-03-11 · 0001193125-26-101126 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2025-12-23 · 0001193125-25-335824 · Items 5.02

  18. 8-K · Current report

    Report date 2025-11-23 · 0001193125-25-292155 · Items 1.01,3.02,8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001660334-25-000006

  20. 8-K · Current report

    Report date 2025-11-14 · 0001193125-25-283078 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-08-08 · 0001193125-25-178954 · Items 2.02,8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107358

  23. 8-K · Current report

    Report date 2025-07-24 · 0001193125-25-169309 · Items 3.01

  24. 8-K · Current report

    Report date 2025-07-22 · 0001193125-25-162939 · Items 3.03,9.01

  25. 8-K · Current report

    Report date 2025-06-27 · 0001193125-25-153471 · Items 1.01,7.01,9.01

  26. 8-K · Current report

    Report date 2025-06-10 · 0001193125-25-139959 · Items 1.01

  27. 8-K · Current report

    Report date 2025-06-05 · 0001193125-25-135949 · Items 5.07

  28. 8-K · Current report

    Report date 2025-05-13 · 0001193125-25-118839 · Items 2.02,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-070452

  30. 8-K · Current report

    Report date 2025-04-22 · 0001193125-25-096909 · Items 5.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0001193125-25-087838

  32. 8-K · Current report

    Report date 2025-03-31 · 0001193125-25-071389 · Items 5.02

  33. 8-K · Current report

    Report date 2025-03-11 · 0001193125-25-051957 · Items 2.02,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-037172

  35. 8-K · Current report

    Report date 2025-02-18 · 0001193125-25-032003 · Items 1.01

  36. 8-K · Current report

    Report date 2025-01-24 · 0001193125-25-017264 · Items 3.01

  37. SC 13G/A · Ownership disclosure

    0001193125-24-273581

  38. 8-K · Current report

    Report date 2024-12-04 · 0001193125-24-273406 · Items 5.02,9.01

  39. SC 13D/A · Ownership disclosure

    0001104659-24-123093

  40. 8-K · Current report

    Report date 2024-11-20 · 0001193125-24-263477 · Items 1.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 7 transaction rows7AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-09
Zawitz DavidA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
171340.00.0
2026-06-05
2026-06-09
Rieger JaysonA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
512269.00.0
2026-06-05
2026-06-09
Eichenfield LawrenceA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
16000.00.0
2026-06-05
2026-06-09
Nguyen DiemA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
16000.00.0
2026-06-05
2026-06-09
Corcoran GavinA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
16000.00.0
2026-06-05
2026-06-09
Rosenberg Noah L.A · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
233840.00.0
2026-06-05
2026-06-09
PRYGOCKI MARK A SRA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
16000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001660334Verrica Pharmaceuticals Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$7.57M$8.05M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗